The drug, meant to treat symptoms related to ADNP syndrome – a rare genetic disease that causes symptoms such as intellectual disability and autism spectrum disorder – has other applications. By JERUSALEM POST STAFF Published: DECEMBER 9, 2021 A Tel Aviv University study found that a drug that was designated as an “orphan drug” by the FDA – meaning […]
